Changchun High-Tech Industries announced that its subsidiary, Changchun Jinsai Pharmaceutical Co., Ltd., has received the "Drug Registration Certificate" issued by the National Medical Products Administration. The progesterone injection (II) 1.112ml:25mg meets the requirements for drug registration and has been approved for registration, and the drug registration certificate has been issued.
长春高新：控股子公司黄体酮注射液（II）获得药品注册证书
Changchun High-Tech Industries: Controlled subsidiary, Progesterone Injection (II) has obtained the pharmaceutical registration certificate.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.